P.2.d.017 Pharmacological profile of Lu AA21004, a novel multi-target drug for the treatment of mood disorders
Arne Mørk(Lundbeck (Denmark)), Tine B. Stensbøl(Kyoto University), Stephanie Bisulco, Anders Blædel Lassen, Benny Bang‐Andersen(Lundbeck (Denmark)), Huailing Zhong(Beaumont Hospital, Royal Oak), Sue Fallon, Kristen Frederiksen(Mayo Clinic in Florida), Lise T. Brennum
Cited by 10
Related Papers
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
|Journal of Medicinal Chemistry|2011|602
Proliferation and differentiation of rat neuroepithelial precursor cells in vivo
|Journal of Neuroscience|1988|560
Immortalization of precursor cells from the mammalian CNS
|Neuron|1988|326
<i>(R)‐N</i>‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier
|Journal of Neurochemistry|1990|228
NNC-711, a novel potent and selective γ-aminobutyric acid uptake inhibitor: pharmacological characterization
|European Journal of Pharmacology|1992|160